Department of Psychology, Lund University, Lund, Sweden.
Nord J Psychiatry. 2023 Oct;77(7):627-640. doi: 10.1080/08039488.2023.2226114. Epub 2023 Jun 27.
Impaired social cognition (SC) occurs frequently in schizophrenia (SCZ), yet compared to autism spectrum disorder (ASD), the research on SC in SCZ is sparse and methodologically heterogeneous. To accurately assess between-group SC differences it is further necessary to establish the relationship between nonsocial cognition (NSC) and SC, particularly as this may not be identical across disorders.
The present study aimed to map, index and assess the quality of research published between 2014-2021 investigating SC in SCZ, and to summarize existing limitations and recommendations for future research.
Following (PRISMA-ScR) fifteen ( 15) case-control studies were identified and included across three electronic databases. Studies additionally utilizing ASD samples were included because of their clinical utility.
Most studies reported significant SC impairments in SCZ relative to healthy controls (HC) with varying effect sizes. Significant differences between SCZ and ASD were not found in most studies including both samples. Weak-to-moderate correlations between SC and NSC were often found, although often only within patient samples. Across studies, SC tests were inconsistently described as measurements of "social cognition", "mentalization" and, most frequently and varyingly, "theory of mind". Most studies lacked methodological transparency. Limitations related to sample sizes and test reliability were most frequently mentioned.
The current research on SC in SCZ is limited by conceptual and methodological uncertainties. Future research should focus on ensuring clear and valid definitions of key terms, evaluating and clarifying SC outcome measures and further untangling the relationship between SC and NSC.
精神分裂症(SCZ)患者常出现社交认知(SC)受损,但与自闭症谱系障碍(ASD)相比,SCZ 患者 SC 的研究较少且方法学上存在差异。为了准确评估组间 SC 差异,有必要进一步确定非社交认知(NSC)与 SC 之间的关系,特别是因为这种关系在不同疾病中可能并不相同。
本研究旨在绘制、索引和评估 2014-2021 年间发表的关于 SCZ 患者 SC 的研究,并总结现有局限性和对未来研究的建议。
按照 PRISMA-ScR 指南,在三个电子数据库中识别并纳入了十五项病例对照研究。由于其临床实用性,还纳入了另外使用 ASD 样本的研究。
大多数研究报告了 SCZ 患者相对于健康对照(HC)存在显著的 SC 受损,且具有不同的效应量。包括两个样本的大多数研究并未发现 SCZ 和 ASD 之间存在显著差异。尽管通常仅在患者样本中,SC 和 NSC 之间存在弱至中度相关性。在研究中,SC 测试被不一致地描述为“社交认知”、“心理化”以及最频繁和变化最多的“心理理论”的测量。大多数研究缺乏方法学透明度。最常提到的局限性与样本量和测试可靠性有关。
目前关于 SCZ 患者 SC 的研究受到概念和方法学不确定性的限制。未来的研究应侧重于确保关键术语的定义清晰有效,评估和澄清 SC 结果测量,并进一步理清 SC 和 NSC 之间的关系。